2,557
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Comparison the effects of progestin-primed ovarian stimulation (PPOS) protocol and GnRH-a long protocol in patients with normal ovarian reserve function

, , , &
Article: 2217263 | Received 28 Mar 2022, Accepted 18 May 2023, Published online: 26 May 2023

References

  • Toftager M, Bogstad J, Bryndorf T, et al. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles. Hum Reprod. 2016;31(6):1–5.
  • Jing M, Lin C, Zhu W, et al. Cost-effectiveness analysis of GnRH-agonist long-protocol and GnRH-antagonist protocol for in vitro fertilization. Sci Rep. 2020;10(1):8732.
  • Chen Q. Editorial: Recent advances in progestin-primed ovarian stimulation. Front Endocrinol (Lausanne). 2022;13:1004352.
  • Kao TC, Hsieh YC, Yang IJ, et al. Progestin-primed ovarian stimulation versus GnRH antagonist protocol in poor responders: Risk of premature LH surge and outcome of oocyte retrieval. J Formos Med Assoc. 2023;122(1):29–35.
  • Chen YM, Qi QR, Xie QZ, et al. Effect of progestin-primed ovarian stimulation protocol on outcomes of aged infertile women who failed to get pregnant in the first IVF/ICSI cycle: a self-controlled study. Curr Med Sci. 2018;38(3):513–518.
  • Liu A, Li J, Shen H, et al. Progestin-primed ovarian stimulation protocol with or without clomiphene citrate for poor ovarian responders: a retrospective cohort study. BMC Womens Health. 2022;22(1):527.
  • Liu Y, Lin J, Yu S, et al. Letrozole cotreatment with progestin-primed ovarian stimulation in women with polycystic ovary syndrome undergoing IVF treatment. Front Physiol. 2022;13:965210.
  • Ziebe S, Petersen K, Lindenberg S, et al. Embryo morphology or cleavage state: how to select the best embryos for transfer after in vitro fertilization. Hum Reprod. 1997;12(7):1545–1549.
  • Kuang Y, Chen Q, Fu Y, et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 2015;104(1):62–70.
  • Fan Y, Sun YF, Xu YM, et al. Factors affecting clinical pregnancy in controlled ovarian hyperstimulation with GnRH-a long protocol: a retrospective cross-sectional study. J Obstet Gynaecol. 2022;42(6):2486–2491.
  • Nathalie M. New stimulation protocols: endogenous and exogenous progesterone use to block the LH surge during ovarian stimulation for IVF. Hum Reprod Update. 2017;23(2):211–220.
  • He W, Li X, Adekunbi D, et al. Hypothalamic effects of progesterone on regulation of the pulsatile and surge release of luteinizing hormone in female rats. Sci Rep. 2017;7(1):80–96.
  • Drakakis P, Loutradis D, Kallianidis K, et al. Small doses of LH activity areneeded early in ovarian stimulationfor better quality oocytes in IVF-ET. Eur J Obstet Gynecol Reprod Biol. 2005;121(1):77–80.
  • Ruan M, Fang L, Yang S, et al. Prolonged pituitary downregulation with gonadotropin-releasing hormone agonist improves the live-birth rate: a retrospective cohort study comparing 3 different protocols. Ann Palliat Med. 2021;10(9):9984–9992.
  • Ganor-Paz Y, Friedler-Mashiach Y, Ghetler Y, et al. What is the best treatment for women with polycystic ovarian syndrome and high LH/FSH ratio? A comparison among invitro fertilization with GnRH agonist, GnRH antagonist and in vitro maturation. J Endocrinol Invest. 2016;39(7):799–803.
  • Xi Q, Tao Y, Qiu M, et al. Comparison between PPOS and GnRHa-Long protocol in clinical outcome with the first IVF/ICSI cycle: a randomized clinical trial. Clin Epidemiol. 2020;12:261–272. volume
  • Huang CY, Chen GY, Shieh ML, et al. Validating the use of corifollitropin alfa in Progestin-Primed ovarian stimulation protocol on normal and high responders by comparing with conventional antagonist protocol: a retrospective study. Life (Basel). 2020;10(6):90.
  • Cui L, Lin Y, Wang F, et al. Effectiveness of progesterone-primed ovarian stimulation in assisted reproductive technology: a systematic review and meta-analysis. Arch Gynecol Obstet. 2021;303(3):615–630.
  • Zhao J, Xu B, Huang X, et al. Whether letrozole could reduce the incidence of early ovary hyperstimulation syndrome after assisted reproductive technology? A systematic review and meta-analysis. Reprod Health. 2020;17(1):181–181.
  • Luo J, Qi Q, Chen Y, et al. Cocktail style treatment of GnRH antagonist, mifepristone and letrozole effectively prevent the progression of ovarian hyperstimulation syndrome in a rat model. Reprod Bio Med Online. 2021;42(2):291–300.